Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
-
-
RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
-
Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTI for treatment of COVID-19
On Jul. 16, 2020, Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study…
-
Telesis Bio Releases New Synthetic SARS-CoV-2 Genome for COVID-19 Vaccine and Therapeutic Research
On Jul. 16, 2020, Telesis Bio announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Medical Device | Non-Profit Research | Oncology | Rare Disease | Stem Cell | Therapeutics | U.S. Congress
Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical Times in US
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
-
Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
On Jul. 16, 2020, Atossa Therapeutics announced that it had contracted with Avance Clinical Pty to conduct a…
-
HKU mechanical engineering study revealed airborne transmission of COVID-19 opportunistic in nature and poor indoor ventilation plays a role in transmission
On Jul. 15, 2020, in collaboration with the Guangdong CDC, Hunan CDC, Sun Yat-Sen University and Southeast University,…
-
BioAegis received approval to proceed with phase 2 trial of its gelsolin COVID-19 treatment
On Jul. 15, 2020, BioAegis Therapeutics announced that it received regulatory clearance from The Spanish Agency for Medicines…
-
AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics
Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility
On Jul. 15, 2020, a Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19. Published…
-
Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19 nasal spray…
-
Biotechnology | Genomics | NIH | Therapeutics
NIH researchers generated complete human X chromosome sequence
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes…
-
Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…
-
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On Jul. 14, 2020, newly designed powered air-purifying respirators (PAPRs), developed by Ford in close collaboration with 3M,…
-
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
-
Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assays
On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…
-
Junshi Biosciences and Lonza announced partnership to produce a neutralizing antibody tackling COVID-19
On Jul. 13, 2020, Lonza and Junshi Biosciences announced that the first healthy volunteer had been dosed in…
-
Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
-
Philips launched obstetrics monitoring solution to support clinicians and expectant mothers during COVID-19 pandemic
On Jul. 12, 2020, Royal Philips announced an addition to its remote patient monitoring suite supporting at-risk populations…
-
Gilead Sciences reported additional data on investigational antiviral remdesivir for treatment of COVID-19
On Jul. 10, 2020, Gilead Sciences announced additional data on remdesivir, an investigational antiviral for the treatment of…
-
Broad Institute launched academic-industry cell imaging consortium to speed drug discovery and development
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
-
UT Southwestern, Texas Health launched collaborative study to better understand COVID prevalence in DFW
On Jul. 10, 2020, SARS-CoV-2, the virus that causes COVID-19, has infected more than 3 million people in…
-
Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths
On Jul. 10, 2020, researchers from Virginia Tech and the National Institutes of Health (NIH) suggested that Bacille…
-
Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
-
ViralClear partnered with Albany Molecular on manufacture of merimepodib API development for potential treatment of COVID-19
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
-
Pfizer pledged $100 million to new industry fund to help fight growing threat of antimicrobial resistance
On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action…
-
Major League Soccer selected OPKO Health’s BioReference Laboratories to provide COVID-19 testing for players and employees
On Jul. 9, 2020, BioReference Laboratories, an OPKO Health company, announced that it will conduct COVID-19 testing for…
-
Mylan and Fujifilm Kyowa Kirin Biologics announced FDA approval of Hulio (adalimumab-fkjp)
On Jul. 9, 2020, Mylan and Fujifilm Kyowa Kirin Biologics announced the the U.S. Food and Drug Administration…
-
Constant Therapeutics’ TXA127 tested in multiple clinical trials for COVID-19 patients
On Jul. 8, 2020, Constant Therapeutics reported that its peptide drug TXA127 was tested in a series of…
-
HPV test missed twice as many women who develop cervical cancer as cotesting
On Jul. 8, 2020, a Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh…
